Capital Planning Advisors, LLC Johnson & Johnson Transaction History

Capital Planning Advisors, LLC

$639 Million
Q3 2024

A detailed history of Capital Planning Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Capital Planning Advisors, LLC holds 25,533 shares of JNJ stock, worth $3.97 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

25,533

Previous 30,794 17.08%

Holding current value

$3.97 Million

Previous $4.5 Million 8.07%

% of portfolio

0.65%

Previous 0.79%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$145.48 - $167.38 $765,370 - $880,586	-5,261 Reduced 17.08%	25,533 $4.14 Million
Q2 2024 Aug 12, 2024	SELL	$144.38 - $157.78 $439,492 - $480,282	-3,044 Reduced 9.0%	30,794 $4.5 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $36,631 - $38,406	-236 Reduced 0.69%	33,838 $5.35 Million
Q4 2023 Feb 12, 2024	SELL	$145.6 - $158.88 $406,078 - $443,116	-2,789 Reduced 7.57%	34,074 $5.34 Million
Q3 2023 Oct 30, 2023	SELL	$155.75 - $174.48 $43,454 - $48,679	-279 Reduced 0.75%	36,863 $5.74 Million
Q2 2023 Aug 01, 2023	SELL	$154.35 - $166.11 $52,787 - $56,809	-342 Reduced 0.91%	37,142 $6.15 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $223,402 - $266,604	-1,479 Reduced 3.8%	37,484 $5.81 Million
Q4 2022 Feb 09, 2023	BUY	$160.2 - $179.79 $514,081 - $576,946	3,209 Added 8.98%	38,963 $6.88 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $423,491 - $471,240	2,625 Added 7.92%	35,754 $5.84 Million
Q2 2022 Aug 10, 2022	BUY	$168.19 - $186.01 $114,537 - $126,672	681 Added 2.1%	33,129 $5.88 Million
Q1 2022 May 10, 2022	BUY	$158.14 - $179.59 $40,009 - $45,436	253 Added 0.79%	32,448 $5.75 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $79,524 - $88,235	510 Added 1.61%	32,195 $5.51 Million
Q3 2021 Nov 09, 2021	SELL	$161.5 - $179.47 $101,099 - $112,348	-626 Reduced 1.94%	31,685 $5.12 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $72,244 - $77,494	-453 Reduced 1.38%	32,311 $5.32 Million
Q1 2021 Apr 30, 2021	SELL	$153.07 - $170.48 $582,890 - $649,187	-3,808 Reduced 10.41%	32,764 $5.39 Million
Q4 2020 Feb 04, 2021	SELL	$137.11 - $157.38 $220,061 - $252,594	-1,605 Reduced 4.2%	36,572 $5.76 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $48,711 - $53,379	-347 Reduced 0.9%	38,177 $5.68 Million
Q2 2020 Aug 06, 2020	BUY	$128.81 - $155.51 $129,325 - $156,132	1,004 Added 2.68%	38,524 $5.42 Million
Q1 2020 May 11, 2020	BUY	$111.14 - $153.99 $1,222 - $1,693	11 Added 0.03%	37,520 $4.92 Million
Q4 2019 Feb 03, 2020	BUY	$127.5 - $146.44 $92,565 - $106,315	726 Added 1.97%	37,509 $5.47 Million
Q3 2019 Nov 05, 2019	SELL	$126.95 - $142.14 $469,715 - $525,918	-3,700 Reduced 9.14%	36,783 $4.76 Million
Q2 2019 Aug 09, 2019	SELL	$131.15 - $144.24 $96,264 - $105,872	-734 Reduced 1.78%	40,483 $5.64 Million
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $230,444 - $256,235	-1,833 Reduced 4.26%	41,217 $5.76 Million
Q4 2018 Feb 13, 2019	BUY	$122.84 - $147.84 $45,205 - $54,405	368 Added 0.86%	43,050 $5.56 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $1.93 Million - $2.27 Million	15,904 Added 59.39%	42,682 $5.9 Million
Q2 2018 Aug 08, 2018	SELL	$119.4 - $131.76 $1.96 Million - $2.17 Million	-16,451 Reduced 38.06%	26,778 $3.25 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $41,408 - $49,034	-331 Reduced 0.76%	43,229 $5.54 Million
Q4 2017 Feb 08, 2018	BUY	$131.22 - $143.62 $128,989 - $141,178	983 Added 2.31%	43,560 $6.09 Million
Q3 2017 Nov 09, 2017	BUY	$129.47 - $135.38 $5.51 Million - $5.76 Million	42,577	42,577 $5.54 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $407B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Planning Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Planning Advisors, LLC with notifications on news.

Account

Capital Planning Advisors, LLC Johnson & Johnson Transaction History